LivaNova PLC (LIVN)
USD 35.56
(-5.14%)
USD 35.56
(-5.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 17.54 Million USD | 120.35% |
| 2022 | -86.2 Million USD | 36.48% |
| 2021 | -135.7 Million USD | 60.47% |
| 2020 | -343.3 Million USD | -120.77% |
| 2019 | -155.5 Million USD | 17.9% |
| 2018 | -189.4 Million USD | -654.58% |
| 2017 | -25.1 Million USD | 60.03% |
| 2016 | -62.8 Million USD | -208.56% |
| 2015 | 57.84 Million USD | 5.39% |
| 2014 | 54.89 Million USD | 18.41% |
| 2013 | 46.35 Million USD | 28.49% |
| 2012 | 36.07 Million USD | -22.79% |
| 2011 | 46.72 Million USD | -40.44% |
| 2010 | 78.44 Million USD | 193.59% |
| 2009 | 26.72 Million USD | 358.55% |
| 2008 | -10.33 Million USD | 79.81% |
| 2007 | -51.18 Million USD | 13.36% |
| 2006 | -59.06 Million USD | -383.45% |
| 2005 | -12.21 Million USD | -280.76% |
| 2004 | 6.75 Million USD | 30.37% |
| 2003 | 5.18 Million USD | 119.85% |
| 2002 | -26.11 Million USD | 0.0% |
| 2000 | -3.05 Million USD | 75.57% |
| 1999 | -12.5 Million USD | 11.97% |
| 1998 | -14.2 Million USD | -26.79% |
| 1997 | -11.2 Million USD | -10.89% |
| 1996 | -10.1 Million USD | -40.28% |
| 1995 | -7.2 Million USD | -22.03% |
| 1994 | -5.9 Million USD | -15.69% |
| 1993 | -5.1 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -41.94 Million USD | -356.7% |
| 2024 Q2 | 16.33 Million USD | 138.94% |
| 2024 Q3 | 32.95 Million USD | 101.76% |
| 2023 Q2 | 1.15 Million USD | -84.33% |
| 2023 Q3 | -7.3 Million USD | -732.03% |
| 2023 FY | 17.54 Million USD | 120.35% |
| 2023 Q4 | 16.33 Million USD | 323.82% |
| 2023 Q1 | 7.37 Million USD | 343.71% |
| 2022 FY | -86.2 Million USD | 36.48% |
| 2022 Q4 | 1.66 Million USD | 101.55% |
| 2022 Q3 | -107.4 Million USD | -753.13% |
| 2022 Q2 | 16.44 Million USD | 449.42% |
| 2022 Q1 | 2.99 Million USD | 158.69% |
| 2021 Q1 | -29.69 Million USD | 89.39% |
| 2021 Q2 | -55.31 Million USD | -86.27% |
| 2021 Q3 | -42.23 Million USD | 23.65% |
| 2021 Q4 | -5.1 Million USD | 87.93% |
| 2021 FY | -135.7 Million USD | 60.47% |
| 2020 Q3 | -14.77 Million USD | 83.21% |
| 2020 FY | -343.3 Million USD | -120.77% |
| 2020 Q2 | -87.99 Million USD | -334.13% |
| 2020 Q1 | 37.58 Million USD | 126.25% |
| 2020 Q4 | -279.8 Million USD | -1794.12% |
| 2019 Q1 | -14.84 Million USD | 92.95% |
| 2019 Q2 | -29.21 Million USD | -96.75% |
| 2019 Q4 | -143.2 Million USD | -545.86% |
| 2019 Q3 | 32.11 Million USD | 209.94% |
| 2019 FY | -155.5 Million USD | 17.9% |
| 2018 Q1 | 13.27 Million USD | 111.88% |
| 2018 Q3 | -7.17 Million USD | -147.64% |
| 2018 Q4 | -210.6 Million USD | -2834.37% |
| 2018 Q2 | 15.06 Million USD | 13.51% |
| 2018 FY | -189.4 Million USD | -654.58% |
| 2017 Q4 | -111.7 Million USD | -501.37% |
| 2017 FY | -25.1 Million USD | 60.03% |
| 2017 Q3 | 27.83 Million USD | -41.41% |
| 2017 Q2 | 47.49 Million USD | 321.42% |
| 2017 Q1 | 11.27 Million USD | 137.82% |
| 2016 Q4 | -29.8 Million USD | -1799.3% |
| 2016 Q3 | -1.56 Million USD | -117.52% |
| 2016 FY | -62.8 Million USD | -208.56% |
| 2016 Q2 | 8.95 Million USD | 122.17% |
| 2016 Q1 | -40.4 Million USD | 0.0% |
| 2015 Q3 | -25.09 Million USD | -302.04% |
| 2015 FY | 57.84 Million USD | 5.39% |
| 2015 Q2 | 12.41 Million USD | 18.12% |
| 2015 Q1 | 10.51 Million USD | -36.44% |
| 2014 Q1 | 18.42 Million USD | 32.58% |
| 2014 Q2 | 13.51 Million USD | -26.64% |
| 2014 Q4 | 16.54 Million USD | -4.24% |
| 2014 Q3 | 17.27 Million USD | 27.77% |
| 2014 FY | 54.89 Million USD | 18.41% |
| 2013 Q3 | 13.88 Million USD | 60.12% |
| 2013 Q4 | 13.89 Million USD | 0.08% |
| 2013 Q1 | 11.53 Million USD | -12.53% |
| 2013 FY | 46.35 Million USD | 28.49% |
| 2013 Q2 | 8.67 Million USD | -24.78% |
| 2012 Q3 | 13.56 Million USD | 68.01% |
| 2012 Q1 | 10.66 Million USD | 12.22% |
| 2012 FY | 36.07 Million USD | -22.79% |
| 2012 Q4 | 13.18 Million USD | -2.83% |
| 2012 Q2 | 8.07 Million USD | -24.27% |
| 2011 Q3 | 9.02 Million USD | 31.13% |
| 2011 FY | 46.72 Million USD | -40.44% |
| 2011 Q4 | 9.5 Million USD | 5.26% |
| 2011 Q2 | 6.88 Million USD | -7.33% |
| 2011 Q1 | 7.42 Million USD | 3.3% |
| 2010 Q2 | 7.16 Million USD | -38.2% |
| 2010 Q1 | 11.59 Million USD | 30.98% |
| 2010 FY | 78.44 Million USD | 193.59% |
| 2010 Q3 | 24.94 Million USD | 248.18% |
| 2010 Q4 | 7.19 Million USD | -71.16% |
| 2009 Q1 | 6.52 Million USD | -33.4% |
| 2009 Q4 | 8.84 Million USD | -82.35% |
| 2009 FY | 26.72 Million USD | 358.55% |
| 2009 Q3 | 50.14 Million USD | 537.52% |
| 2009 Q2 | 7.86 Million USD | 20.58% |
| 2008 FY | -10.33 Million USD | 79.81% |
| 2008 Q2 | 2.05 Million USD | -29.3% |
| 2008 Q4 | 9.79 Million USD | 17.3% |
| 2008 Q1 | 2.9 Million USD | 391.12% |
| 2008 Q3 | 8.35 Million USD | 306.77% |
| 2007 Q2 | -8.16 Million USD | 24.19% |
| 2007 Q1 | -10.76 Million USD | 44.45% |
| 2007 Q3 | -4.07 Million USD | 50.05% |
| 2007 Q4 | -997.31 Thousand USD | 75.54% |
| 2007 FY | -51.18 Million USD | 13.36% |
| 2006 Q1 | -3.53 Million USD | 75.79% |
| 2006 Q4 | -19.38 Million USD | -55.16% |
| 2006 Q3 | -12.49 Million USD | -46.41% |
| 2006 FY | -59.06 Million USD | -383.45% |
| 2006 Q2 | -8.53 Million USD | -141.4% |
| 2005 FY | -12.21 Million USD | -280.76% |
| 2005 Q4 | -14.6 Million USD | 33.83% |
| 2005 Q3 | -22.07 Million USD | -17.01% |
| 2005 Q2 | -18.86 Million USD | -191.69% |
| 2005 Q1 | -6.46 Million USD | -691.16% |
| 2004 Q1 | -1.24 Million USD | -178.09% |
| 2004 Q2 | -2.9 Million USD | -133.53% |
| 2004 Q3 | -2.02 Million USD | 30.34% |
| 2004 FY | 6.75 Million USD | 30.37% |
| 2004 Q4 | -817.28 Thousand USD | 59.67% |
| 2003 Q2 | 2.56 Million USD | -36.49% |
| 2003 Q4 | 1.59 Million USD | -58.55% |
| 2003 FY | 5.18 Million USD | 119.85% |
| 2003 Q1 | 4.03 Million USD | 5.56% |
| 2003 Q3 | 3.84 Million USD | 50.2% |
| 2002 Q3 | 1 Million USD | 127.32% |
| 2002 Q4 | 3.82 Million USD | 280.6% |
| 2002 FY | -26.11 Million USD | 0.0% |
| 2002 Q2 | -3.67 Million USD | 46.57% |
| 2002 Q1 | -6.87 Million USD | -19.1% |
| 2001 Q3 | -6.82 Million USD | -2.91% |
| 2001 Q2 | -6.63 Million USD | -45.57% |
| 2001 Q4 | -5.77 Million USD | 15.44% |
| 2001 Q1 | -4.55 Million USD | -32.35% |
| 2000 Q2 | -2.06 Million USD | -15261.41% |
| 2000 Q1 | 13.62 Thousand USD | 106.81% |
| 2000 FY | -3.05 Million USD | 75.57% |
| 2000 Q4 | -3.44 Million USD | 65.37% |
| 2000 Q3 | -9.94 Million USD | -381.35% |
| 1999 Q2 | -700 Thousand USD | 78.13% |
| 1999 Q1 | -3.2 Million USD | 17.95% |
| 1999 Q3 | -800 Thousand USD | -14.29% |
| 1999 Q4 | -200 Thousand USD | 75.0% |
| 1999 FY | -12.5 Million USD | 11.97% |
| 1998 FY | -14.2 Million USD | -26.79% |
| 1998 Q4 | -3.9 Million USD | 17.02% |
| 1998 Q3 | -4.7 Million USD | 7.84% |
| 1998 Q2 | -5.1 Million USD | -200.0% |
| 1998 Q1 | -1.7 Million USD | 32.0% |
| 1997 Q1 | -3.1 Million USD | -14.81% |
| 1997 FY | -11.2 Million USD | -10.89% |
| 1997 Q4 | -2.5 Million USD | 50.0% |
| 1997 Q3 | -5 Million USD | -35.14% |
| 1997 Q2 | -3.7 Million USD | -19.35% |
| 1996 Q1 | -2.3 Million USD | 8.0% |
| 1996 Q2 | -3.2 Million USD | -39.13% |
| 1996 Q3 | -1.8 Million USD | 43.75% |
| 1996 Q4 | -2.7 Million USD | -50.0% |
| 1996 FY | -10.1 Million USD | -40.28% |
| 1995 Q4 | -2.5 Million USD | -19.05% |
| 1995 Q1 | -1.6 Million USD | 0.0% |
| 1995 FY | -7.2 Million USD | -22.03% |
| 1995 Q3 | -2.1 Million USD | 12.5% |
| 1995 Q2 | -2.4 Million USD | -50.0% |
| 1994 Q4 | -1.6 Million USD | 0.0% |
| 1994 FY | -5.9 Million USD | -15.69% |
| 1994 Q1 | -1.4 Million USD | 17.65% |
| 1994 Q2 | -1.3 Million USD | 7.14% |
| 1994 Q3 | -1.6 Million USD | -23.08% |
| 1993 FY | -5.1 Million USD | 0.0% |
| 1993 Q1 | -1.1 Million USD | 0.0% |
| 1993 Q4 | -1.7 Million USD | -13.33% |
| 1993 Q2 | -1.5 Million USD | -36.36% |
| 1993 Q3 | -1.5 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 128.475% |
| BrainsWay Ltd. | -4.19 Million USD | 518.061% |
| Cerus Corporation | -37.48 Million USD | 146.803% |
| Envoy Medical, Inc. | -29.9 Million USD | 158.667% |
| electroCore, Inc. | -18.83 Million USD | 193.161% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 298.26% |
| IceCure Medical Ltd | -14.65 Million USD | 219.752% |
| Inogen, Inc. | -102.44 Million USD | 117.127% |
| OrthoPediatrics Corp. | -20.97 Million USD | 183.656% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 133.316% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 227.652% |
| MaxCyte, Inc. | -37.92 Million USD | 146.267% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 247.949% |
| Nexalin Technology, Inc. | -4.64 Million USD | 477.438% |
| Orthofix Medical Inc. | -151.39 Million USD | 111.59% |
| PAVmed Inc | -64.17 Million USD | 127.341% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 133.442% |
| RxSight, Inc. | -48.6 Million USD | 136.097% |
| Sight Sciences, Inc. | -55.54 Million USD | 131.588% |
| SI-BONE, Inc. | -43.33 Million USD | 140.488% |
| TELA Bio, Inc. | -46.66 Million USD | 137.601% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 135.427% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 229.176% |
| Acutus Medical, Inc. | -81.66 Million USD | 121.486% |
| Talis Biomedical Corporation | -62 Million USD | 128.297% |
| Spectral AI, Inc. | -20.85 Million USD | 184.137% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 128.87% |
| CVRx, Inc. | -41.19 Million USD | 142.588% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -2640.723% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 260.16% |
| Bioventus Inc. | -156.23 Million USD | 111.231% |
| Venus Concept Inc. | -37.25 Million USD | 147.103% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 129.72% |
| 908 Devices Inc. | -36.39 Million USD | 148.205% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 109.401% |
| Nemaura Medical Inc. | -14.14 Million USD | 224.055% |
| NeuroPace, Inc. | -32.95 Million USD | 153.241% |
| LENSAR, Inc. | -14.38 Million USD | 221.991% |
| Apyx Medical Corporation | -18.71 Million USD | 193.764% |
| Cutera, Inc. | -162.83 Million USD | 110.775% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 262.013% |
| BioSig Technologies, Inc. | -29.04 Million USD | 160.418% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 121.225% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 179.433% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 74.098% |
| Axonics, Inc. | -6.08 Million USD | 388.206% |
| Outset Medical, Inc. | -172.79 Million USD | 110.154% |
| IRIDEX Corporation | -9.57 Million USD | 283.344% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 116.569% |
| IRadimed Corporation | 17.19 Million USD | -2.054% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 312.834% |
| INVO Bioscience, Inc. | -8.03 Million USD | 318.38% |
| Telesis Bio, Inc. | -47.72 Million USD | 136.766% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -71.297% |
| Varex Imaging Corporation | -47.7 Million USD | 136.784% |
| Quipt Home Medical Corp. | -2.78 Million USD | 730.244% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 255.467% |
| Pulmonx Corporation | -60.84 Million USD | 128.838% |
| Dynatronics Corporation | -2.69 Million USD | 750.401% |
| Modular Medical, Inc. | -17.47 Million USD | 200.435% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 254.088% |
| Semler Scientific, Inc. | 20.58 Million USD | 14.755% |
| InMode Ltd. | 197.91 Million USD | 91.135% |
| Bruker Corporation | 427.2 Million USD | 95.893% |
| Cytosorbents Corporation | -28.5 Million USD | 161.549% |
| DexCom, Inc. | 541.5 Million USD | 96.76% |
| Align Technology, Inc. | 445.05 Million USD | 96.058% |
| Viveve Medical, Inc. | -22.02 Million USD | 179.657% |
| ZimVie Inc. | -393.28 Million USD | 104.461% |
| Movano Inc. | -29.28 Million USD | 159.919% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 244.435% |
| Nexalin Technology, Inc. | -4.64 Million USD | 477.438% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -2640.723% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 107.882% |
| Profound Medical Corp. | -28.56 Million USD | 161.416% |
| Insulet Corporation | 206.3 Million USD | 91.495% |
| enVVeno Medical Corporation | -23.51 Million USD | 174.613% |
| Surmodics, Inc. | -11.54 Million USD | 252.019% |
| iCAD, Inc. | -4.84 Million USD | 461.997% |
| Nuwellis, Inc. | -20.2 Million USD | 186.823% |
| Biotricity, Inc. | -14.09 Million USD | 224.49% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 114.218% |
| Aethlon Medical, Inc. | -12.2 Million USD | 243.723% |
| InspireMD, Inc. | -19.91 Million USD | 188.1% |
| PAVmed Inc. | -64.17 Million USD | 127.341% |
| BIOLASE, Inc. | -20.63 Million USD | 185.043% |
| Beyond Air, Inc. | -60.24 Million USD | 129.126% |
| FONAR Corporation | 10.56 Million USD | -66.039% |
| AxoGen, Inc. | -21.71 Million USD | 180.798% |
| Vivani Medical, Inc. | -25.65 Million USD | 168.4% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 38.467% |
| Inari Medical, Inc. | -1.63 Million USD | 1172.494% |
| UFP Technologies, Inc. | 44.92 Million USD | 60.943% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 441.872% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 365.639% |
| Tenon Medical, Inc. | -15.58 Million USD | 212.612% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 213.743% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 149.659% |
| AdaptHealth Corp. | -678.89 Million USD | 102.584% |
| Sintx Technologies, Inc. | -8.25 Million USD | 312.447% |
| NanoVibronix, Inc. | -3.71 Million USD | 572.811% |
| Quanterix Corporation | -32.33 Million USD | 154.265% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 255.467% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -3517.732% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 105.72% |
| TransMedics Group, Inc. | -25.02 Million USD | 170.105% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 179.275% |
| NeuroMetrix, Inc. | -6.52 Million USD | 368.719% |
| Hyperfine, Inc. | -44.23 Million USD | 139.663% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 122.351% |
| Biomerica, Inc. | -5.97 Million USD | 393.51% |
| Bone Biologics Corporation | -8.94 Million USD | 296.072% |
| AVITA Medical, Inc. | -39.16 Million USD | 144.797% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 276.273% |
| Silk Road Medical, Inc | -55.74 Million USD | 131.477% |